A clinical-stage natural psychedelic drug development company. $FLHLF $7QS

Joined April 2021
64 Photos and videos
Filament Health retweeted
Today, @TheraPsil alongside @SabiMind and @FilamentHealth launched the first wellness-focused & stakeholder-funded psilocybin clinical trial. Psychedelic research is about to change. See full release here: therapsil.ca/press-psilwell-…
1
5
242
Today we announced positive data from a phase 2 study of PEX010 in patients with alcohol use disorder. The study found that after 1 dose of #psilocybin, the mean % of heavy drinking days was reduced by more than 50% over the 12-week observation period. filament.health/news/filamen…
2
1
7
498
Filament Health retweeted
.@benlightburn @FilamentHealth discusses the company’s approach to psychedelic medicine, the case for natural botanical extracts rather than synthetic compounds, and its lead experimental therapy that targets methamphetamine use disorder. thebioreport.podbean.com/e/e…
1
3
260
We're proud to supply our botanical psilocybin drug candidate for this much-needed research into opioid use disorder at @imperialcollege.
A groundbreaking clinical trial will explore the use of psilocybin, the active compound in magic mushrooms, to combat opioid addiction. 🍄 This ‘first in the UK’ study aims to help prevent relapse with the power of psychedelics and psychological support. imperial.ac.uk/news/257294/i…
268
Today we announced a major expansion of our IP portfolio, with 12 new patents accepted in Australia, 5 in Canada, & 3 in the US. Filament holds a total of 46 allowed patents relating to the development & delivery of naturally-derived psychedelic APIs. filament.health/news/filamen…
2
184
Today we announced authorization by both @US_FDA & @GovCanHealth of a Phase 2 clinical trial studying PEX010 for methamphetamine use disorder. This is the first ever clinical trial to study the safety & efficacy of botanical #psilocybin for MAUD. filament.health/news/filamen…
1
3
205
Our CEO @benlightburn will be hosting an #AMA with @ceodotca at 12PM ET tomorrow to discuss our latest news and developments. Submit questions for Ben via: ceo.ca/@ceoca_james
2
271
We're pleased to report our 2023 year-end results including $2.1 million in revenue @GovCanHealth approval of a Filament-sponsored Phase 2 clinical trial studying our botanical psilocybin for opioid use disorder at @UBC. filament.health/news/filamen…
1
171
Filament Health retweeted
Join Robert Sassoon for a fireside chat with @FilamentHealth CEO Ben Lightburn on Thursday, April 4th, at 12:00 pm ET. #psychedelics #psychedelictherapy #therapeutics us06web.zoom.us/webinar/regi…
1
1
258
Read about @UCalgary's upcoming study which will examine the effects of our botanical #psilocybin for alcohol use disorder:
Can the power of magic mushrooms overcome the pull of alcohol use disorder? 🍄🍻 An upcoming study based in Canada aims to shed light on the potential for psilocybin’s role in battling the beast that is alcohol addiction. hightimes.com/study/study-ai…
1
211
We're proud to supply our botanical psilocybin for this important research at @UCalgary:
Mushrooms' potential magic in quelling alcohol abuse the focus of U of C researchers #yyc calgaryherald.com/news/local…
3
207
Filament Health retweeted
13 Mar 2024
2024 is set to be a watershed year for #Psychedelics. Alongside an influx of biotech investment in the UK, the industry has seen significant milestones set to accelerate the sector, return confidence & advance #MentalHealth innovations. Find out more. 👇 psychedelichealth.co.uk/2024…
1
2
3
452
"We developed specific technology that has allowed us to create the first & only pharmaceutical grade natural psychedelic drug candidates." - CEO @benlightburn spoke to @PharmExec Magazine about our novel approach to psychedelic drug development. pharmexec.com/view/business-…
1
3
256